Alkermes (ALKS) Financials

$37.48 -0.88 (-2.29%)

Closing price 05/15/2026 04:00 PM Eastern

Extended Trading

$37.13 -0.35 (-0.93%)

As of 05/15/2026 04:37 PM Eastern

Annual Income Statements for Alkermes

This table shows Alkermes' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-227	-208	-158	-139	-195	-110	-51	-165	364	368	242
Consolidated Net Income / (Loss)	-227	-208	-158	-139	-197	-111	-48	-158	356	367	242
Net Income / (Loss) Continuing Operations	-227	-208	-158	-139	-197	-111	76	-33	519	372	242
Total Pre-Tax Income	-224	-214	-143	-127	-197	-97	88	-31	422	444	291
Total Operating Income	-224	-209	-148	-99	-175	-112	98	-6.09	414	421	254
Total Gross Profit	489	614	749	918	991	860	976	894	1,410	1,312	1,279
Total Revenue	628	746	903	1,094	1,171	1,039	1,174	1,112	1,663	1,558	1,476
Operating Revenue	628	746	903	1,094	1,171	1,039	1,174	1,112	1,663	1,558	1,476
Total Cost of Revenue	139	132	155	176	180	178	197	218	253	245	196
Operating Cost of Revenue	139	132	155	176	180	178	197	218	253	245	196
Total Operating Expenses	714	822	897	1,017	1,166	973	879	900	996	892	1,025
Selling, General & Admin Expense	312	374	422	526	599	539	550	591	690	645	702
Research & Development Expense	344	387	413	425	513	395	291	273	271	245	324
Amortization Expense	58	61	62	65	40	39	38	36	36	1.10	0.00
Total Other Income / (Expense), net	0.30	-5.72	4.63	-28	-22	16	-10	-25	7.40	23	37
Interest Expense	13	15	12	15	14	8.66	11	13	23	23	12
Interest & Investment Income	3.33	3.75	4.65	9.24	14	6.96	2.41	7.63	31	42	45
Other Income / (Expense), net	10	5.42	12	-22	-22	18	-1.21	-20	-0.43	3.24	4.47
Income Tax Expense	3.16	-5.94	15	12	-0.44	14	11	2.02	-98	72	50
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-	-125	-125	-163	-5.07	0.00
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-0.52	0.52	-0.51	-1.46	-0.47	2.37	7.17	-7.78	-1.14	0.13
Basic Earnings per Share	($1.52)	($1.38)	($1.03)	($0.90)	($1.25)	($0.70)	($0.30)	($0.97)	$2.14	$2.22	$1.47
Weighted Average Basic Shares Outstanding	149.21M	151.48M	153.42M	155.11M	157.05M	158.80M	160.94M	163.74M	166.22M	165.39M	164.70M
Diluted Earnings per Share	($1.52)	($1.38)	($1.03)	($0.90)	($1.25)	($0.70)	($0.29)	($0.97)	$2.10	$2.17	$1.43
Weighted Average Diluted Shares Outstanding	149.21M	151.48M	153.42M	155.11M	157.05M	158.80M	164.75M	163.74M	169.73M	169.20M	168.74M
Weighted Average Basic & Diluted Shares Outstanding	149.21M	151.48M	153.42M	155.11M	157.05M	158.80M	160.94M	164.39M	167.08M	162.61M	166.65M

This table shows Alkermes' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	49	116	36	91	96	144	23	87	83	48	-67
Consolidated Net Income / (Loss)	48	113	37	91	92	147	22	87	83	49	-66
Net Income / (Loss) Continuing Operations	92	161	39	95	93	146	22	87	83	49	-66
Total Pre-Tax Income	93	58	47	117	110	170	25	105	101	60	-62
Total Operating Income	89	55	43	110	105	163	14	93	89	58	-48
Total Gross Profit	319	307	292	338	315	368	257	341	343	338	331
Total Revenue	381	377	350	399	378	430	307	391	394	385	393
Operating Revenue	381	377	350	399	378	430	307	391	394	385	393
Total Cost of Revenue	61	70	59	61	63	62	49	49	52	46	62
Operating Cost of Revenue	61	70	59	61	63	62	49	49	52	46	62
Total Operating Expenses	230	253	248	228	210	205	244	248	254	280	380
Selling, General & Admin Expense	156	170	180	168	150	147	172	171	172	187	265
Research & Development Expense	65	74	68	60	60	58	72	77	82	93	103
Amortization Expense	9.00	9.00	1.06	0.01	0.01	0.01	0.00	0.00	0.00	-	12
Total Other Income / (Expense), net	3.51	3.69	3.60	6.84	5.47	7.20	12	12	12	2.27	-14
Interest Expense	6.01	6.05	5.98	5.95	6.00	4.65	0.00	0.00	0.00	12	21
Interest & Investment Income	9.37	9.75	9.40	11	11	11	10	11	12	12	8.54
Other Income / (Expense), net	0.15	-0.01	0.18	2.05	0.56	0.45	1.56	0.77	-0.28	2.42	-1.29
Income Tax Expense	1.15	-102	7.96	22	17	24	3.03	18	18	11	4.55
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-1.36	-2.96	0.49	-0.01	-4.02	2.39	-0.51	-0.06	-0.34	1.04	0.57
Basic Earnings per Share	$0.29	$0.67	$0.22	$0.54	$0.57	$0.89	$0.14	$0.53	$0.50	$0.30	($0.40)
Weighted Average Basic Shares Outstanding	166.61M	166.22M	167.98M	168.32M	163.37M	165.39M	163.41M	164.96M	165.09M	164.70M	166.20M
Diluted Earnings per Share	$0.28	$0.69	$0.21	$0.53	$0.55	$0.88	$0.13	$0.52	$0.49	$0.29	($0.40)
Weighted Average Diluted Shares Outstanding	171.90M	169.73M	172.98M	170.98M	167.03M	169.20M	168.74M	168.36M	168.51M	168.74M	166.20M
Weighted Average Basic & Diluted Shares Outstanding	166.88M	167.08M	169.22M	164.67M	161.80M	162.61M	164.90M	165.08M	165.12M	166.65M	166.68M

This table details how cash moves in and out of Alkermes' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-43	5.27	4.92	75	-63	69	65	-45	165	-166	829
Net Cash From Operating Activities	-40	-64	19	99	72	83	102	21	401	439	521
Net Cash From Continuing Operating Activities	-40	-64	19	99	72	83	102	21	401	439	521
Net Income / (Loss) Continuing Operations	-227	-208	-158	-139	-197	-111	-48	-158	356	367	242
Consolidated Net Income / (Loss)	-227	-208	-158	-139	-197	-111	-48	-158	356	367	242
Depreciation Expense	86	94	99	104	80	82	79	78	75	29	27
Non-Cash Adjustments To Reconcile Net Income	55	95	105	115	104	87	115	119	127	106	84
Changes in Operating Assets and Liabilities, net	47	-45	-26	20	85	25	-43	-18	-156	-62	168
Net Cash From Investing Activities	-43	127	-18	-22	-142	-11	-66	-65	53	-111	295
Net Cash From Continuing Investing Activities	-43	127	-18	-22	-142	-11	-66	-65	53	-111	295
Purchase of Property, Plant & Equipment	-53	-44	-51	-69	-91	-42	-28	-38	-48	-33	-40
Purchase of Investments	-509	-375	-432	-398	-278	-230	-340	-310	-254	-487	-364
Sale of Property, Plant & Equipment	0.54	0.19	0.16	0.51	0.90	0.64	0.29	0.00	0.35	0.46	1.09
Divestitures	50	-	-	-	-	-	-	0.00	0.00	98	1.71
Sale and/or Maturity of Investments	468	561	464	444	225	256	295	282	356	310	697
Other Investing Activities, net	-	-	0.00	0.00	10	3.89	6.94	1.76	0.00	0.04	0.00
Net Cash From Financing Activities	41	-58	4.08	-1.62	6.77	-2.17	29	-1.57	-290	-494	12
Net Cash From Continuing Financing Activities	41	-58	4.08	-1.62	6.77	-2.17	29	-1.57	-290	-494	12
Repayment of Debt	-6.75	-69	-3.00	-2.88	-2.84	-2.84	-3.24	-3.00	-3.00	-292	0.00
Repurchase of Common Equity	-	-	-	-	-	-	-	0.00	0.00	-200	0.00
Issuance of Common Equity	45	20	24	21	19	8.37	25	20	17	28	43
Other Financing Activities, net	2.67	-9.24	-16	-20	-9.32	-7.70	-17	-18	-303	-30	-31
Cash Interest Paid	12	12	11	13	13	8.29	6.90	14	23	23	0.00
Cash Income Taxes Paid	0.71	5.53	2.99	0.75	2.51	0.62	1.89	21	44	2.59	5.24

This table details how cash moves in and out of Alkermes' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-18	-190	-37	114	-139	-105	109	121	95	503	-768
Net Cash From Operating Activities	100	107	21	146	82	190	99	150	102	170	-166
Net Cash From Continuing Operating Activities	100	107	21	146	82	190	99	150	102	170	-166
Net Income / (Loss) Continuing Operations	48	113	37	91	92	147	22	87	83	49	-66
Consolidated Net Income / (Loss)	48	113	37	91	92	147	22	87	83	49	-66
Depreciation Expense	19	19	8.06	6.66	6.97	6.85	7.42	7.82	8.08	3.85	19
Amortization Expense	-	-	-	-	-	-	0.00	-	-	-	13
Non-Cash Adjustments To Reconcile Net Income	29	58	12	41	41	10	4.21	33	26	22	41
Changes in Operating Assets and Liabilities, net	4.24	-82	-35	6.84	-58	27	65	22	-15	95	-172
Net Cash From Investing Activities	-119	-21	-40	52	-109	-14	9.10	-29	-6.74	322	-2,077
Net Cash From Continuing Investing Activities	-119	-21	-40	52	-109	-14	9.10	-29	-6.74	322	-2,077
Purchase of Property, Plant & Equipment	-14	-17	-8.34	-7.11	-8.26	-9.77	-10	-13	-17	0.02	-4.09
Acquisitions	-	-	-	-	-	-	0.00	-	-	-	-2,085
Purchase of Investments	-156	-68	-115	-95	-187	-90	-96	-98	-115	-56	-30
Sale of Property, Plant & Equipment	0.00	0.35	0.41	0.02	0.02	0.01	1.71	-1.68	-	1.05	0.01
Sale and/or Maturity of Investments	51	64	82	56	86	86	113	82	125	377	43
Net Cash From Financing Activities	1.57	-276	-18	-83	-111	-282	0.75	0.41	0.32	11	1,475
Net Cash From Continuing Financing Activities	1.57	-276	-18	-83	-111	-282	0.75	0.41	0.32	11	1,475
Repayment of Debt	-0.75	-0.75	-0.75	-0.75	-0.75	-290	0.00	-	-	-	-1.61
Repurchase of Common Equity	-	-	-	-	-116	-0.00	0.00	-	-	-	-28
Issuance of Debt	-	-	-	-	-	-	0.00	-	-	-	1,512
Issuance of Common Equity	3.11	1.65	11	2.61	5.52	8.22	30	2.08	0.62	11	16
Other Financing Activities, net	-0.80	-277	-28	-0.65	-0.29	-0.34	-29	-1.68	-0.31	-0.27	-23
Cash Income Taxes Paid	-	-	-	-	-	-	0.46	-	-	2.13	1.85

This table presents Alkermes' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	1,856	1,726	1,797	1,825	1,805	1,950	2,024	1,964	2,136	2,056	2,487
Total Current Assets	755	791	809	983	962	1,111	1,062	1,130	1,486	1,415	1,929
Cash & Equivalents	181	186	191	267	204	273	338	292	457	291	389
Restricted Cash	-	-	-	-	-	-	-	-	-	0.00	731
Short-Term Investments	354	311	242	273	331	362	199	316	316	461	200
Accounts Receivable	155	191	234	292	257	275	313	288	332	385	334
Inventories, net	38	63	93	90	102	126	150	181	186	183	197
Prepaid Expenses	26	39	48	53	60	61	49	41	98	91	79
Other Current Assets	-	-	0.00	8.23	8.39	25	13	8.93	95	4.99	0.00
Plant, Property, & Equipment, net	255	265	285	310	362	350	341	223	227	228	222
Total Noncurrent Assets	846	671	704	532	481	479	621	611	424	413	336
Long-Term Investments	264	122	157	81	79	25	229	132	40	73	0.15
Goodwill	93	93	93	93	93	93	93	83	85	84	83
Intangible Assets	379	318	256	191	151	111	74	38	-	-	0.82
Noncurrent Deferred & Refundable Income Taxes	41	48	99	86	97	86	82	115	196	155	126
Other Noncurrent Operating Assets	69	90	99	81	62	163	143	206	103	101	126
Total Liabilities & Shareholders' Equity	1,856	1,726	1,797	1,825	1,805	1,950	2,024	1,964	2,136	2,056	2,487
Total Liabilities	541	517	594	654	720	883	912	920	934	591	668
Total Current Liabilities	236	212	291	340	391	438	471	498	520	465	543
Short-Term Debt	66	3.00	3.00	2.84	2.84	19	3.00	3.00	3.00	0.00	0.00
Accounts Payable	169	207	286	334	373	412	208	220	241	185	290
Accrued Expenses	-	-	-	-	-	-	237	252	264	272	247
Current Deferred Revenue	1.74	1.94	1.96	3.17	6.77	-	-	-	2.73	1.25	0.00
Other Current Liabilities	-	-	-	0.00	8.47	7.51	23	17	5.75	6.17	6.75
Total Noncurrent Liabilities	305	305	303	314	329	444	441	422	413	125	124
Long-Term Debt	284	281	278	276	274	272	293	290	288	0.00	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	-	-	-	-	-	-	0.00
Other Noncurrent Operating Liabilities	13	17	19	28	32	53	148	119	126	125	124
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,314	1,209	1,203	1,171	1,085	1,067	1,113	1,044	1,203	1,465	1,819
Total Preferred & Common Equity	1,314	1,209	1,203	1,171	1,085	1,067	1,113	1,044	1,203	1,465	1,819
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,314	1,209	1,203	1,171	1,085	1,067	1,113	1,044	1,203	1,465	1,819
Common Stock	2,116	2,233	2,340	2,469	2,588	2,687	2,800	2,915	2,739	2,863	3,006
Retained Earnings	-739	-948	-1,044	-1,185	-1,382	-1,493	-1,541	-1,699	-1,344	-976	-735
Treasury Stock	-59	-73	-89	-109	-118	-126	-143	-161	-189	-419	-450
Accumulated Other Comprehensive Income / (Loss)	-3.80	-3.27	-3.79	-3.28	-1.82	-1.35	-3.72	-11	-3.11	-1.97	-2.10

This table presents Alkermes' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	1,942	1,923	2,187	2,279	2,124	2,207	2,155	2,082	2,253	2,330	4,258
Total Current Assets	1,054	1,110	1,397	1,465	1,469	1,542	1,564	1,479	1,635	1,742	1,359
Cash & Equivalents	264	321	666	648	421	535	396	400	521	616	352
Restricted Cash	-	-	-	-	-	-	-	-	-	-	0.00
Short-Term Investments	316	279	163	241	324	341	513	484	495	495	160
Accounts Receivable	257	269	334	338	316	366	367	319	355	354	408
Inventories, net	166	185	189	192	198	195	191	183	192	191	337
Prepaid Expenses	40	47	44	43	112	101	94	90	71	84	102
Other Current Assets	10	8.43	0.00	2.77	98	3.49	2.97	3.05	1.42	0.72	0.00
Plant, Property, & Equipment, net	326	321	324	328	225	223	225	234	239	247	221
Total Noncurrent Assets	562	492	466	487	430	442	366	369	378	341	2,679
Long-Term Investments	167	92	78	106	63	86	19	32	38	28	26
Goodwill	93	93	93	93	83	84	84	84	84	84	596
Intangible Assets	47	29	20	11	0.93	-	-	-	-	-	1,784
Noncurrent Deferred & Refundable Income Taxes	137	151	153	162	183	167	160	152	156	130	135
Other Noncurrent Operating Assets	118	126	122	114	101	104	103	101	100	99	138
Total Liabilities & Shareholders' Equity	1,942	1,923	2,187	2,279	2,124	2,207	2,155	2,082	2,253	2,330	4,258
Total Liabilities	899	917	907	924	869	923	863	570	628	596	2,507
Total Current Liabilities	470	493	487	503	459	516	454	444	506	474	599
Short-Term Debt	3.00	3.00	3.00	3.00	3.00	3.00	3.00	-	-	-	27
Accounts Payable	211	190	243	243	206	240	160	186	246	215	293
Accrued Expenses	236	282	223	238	241	263	282	250	253	253	273
Current Deferred Revenue	-	-	-	-	3.34	3.31	2.34	1.61	0.58	0.00	0.00
Other Current Liabilities	20	17	18	18	5.91	6.01	6.15	6.29	6.46	6.63	7.58
Total Noncurrent Liabilities	429	424	420	421	410	407	409	127	122	122	1,907
Long-Term Debt	291	290	289	288	287	286	286	-	-	-	1,484
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	-	-	-	-	-	-	182
Other Noncurrent Operating Liabilities	139	135	131	132	123	121	124	127	122	122	241
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,043	1,006	1,280	1,356	1,255	1,284	1,292	1,512	1,625	1,733	1,752
Total Preferred & Common Equity	1,043	1,006	1,280	1,356	1,255	1,284	1,292	1,512	1,625	1,733	1,752
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,043	1,006	1,280	1,356	1,255	1,284	1,292	1,512	1,625	1,733	1,752
Common Stock	2,887	2,940	2,978	3,005	2,783	2,806	2,834	2,915	2,943	2,969	3,057
Retained Earnings	-1,671	-1,741	-1,504	-1,456	-1,307	-1,215	-1,123	-954	-867	-784	-801
Treasury Stock	-161	-186	-186	-187	-218	-303	-419	-448	-450	-450	-501
Accumulated Other Comprehensive Income / (Loss)	-13	-8.13	-7.44	-6.07	-3.60	-3.59	0.43	-1.46	-1.40	-1.06	-2.91

This table displays calculated financial ratios and metrics derived from Alkermes' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	1.54%	18.68%	21.15%	21.13%	7.01%	-11.29%	13.00%	-5.28%	49.61%	-6.36%	-5.25%
EBITDA Growth	-234.52%	15.17%	65.69%	54.25%	-584.00%	88.90%	1,449.28%	-70.24%	837.05%	-7.41%	-36.87%
EBIT Growth	-8,227.03%	5.06%	33.13%	11.14%	-63.48%	51.96%	201.79%	-126.64%	1,708.65%	2.46%	-39.03%
NOPAT Growth	-157.39%	6.97%	29.12%	32.98%	-77.02%	35.93%	208.17%	-105.01%	12,066.46%	-30.84%	-40.31%
Net Income Growth	-655.67%	8.24%	24.23%	11.80%	-41.14%	43.62%	56.55%	-228.57%	324.78%	3.18%	-34.16%
EPS Growth	-623.81%	9.21%	25.36%	12.62%	-38.89%	44.00%	58.57%	-234.48%	316.49%	3.33%	-34.10%
Operating Cash Flow Growth	-462.33%	-58.08%	130.08%	417.36%	-27.40%	14.94%	22.78%	-79.31%	1,807.21%	9.41%	18.59%
Free Cash Flow Firm Growth	-120.04%	-116.53%	20.43%	94.79%	-531.14%	-265.07%	275.76%	-76.08%	546.49%	-1.13%	-11.62%
Invested Capital Growth	-9.00%	1.00%	2.24%	-7.05%	-9.91%	9.24%	-21.37%	-10.33%	18.80%	-6.49%	-21.94%
Revenue Q/Q Growth	-1.88%	7.25%	7.35%	3.83%	9.03%	-11.33%	3.94%	-1.75%	4.58%	3.49%	-2.99%
EBITDA Q/Q Growth	-1,078.83%	32.76%	47.21%	-366.03%	-5.82%	-151.00%	3,925.51%	-22.73%	-11.24%	27.23%	-27.00%
EBIT Q/Q Growth	-113.91%	19.82%	19.47%	-13.24%	-0.53%	-67.63%	231.37%	-117.19%	-12.80%	34.41%	-28.42%
NOPAT Q/Q Growth	-29.70%	17.26%	16.57%	-6.23%	-6.01%	-22.69%	294.89%	-178.74%	12.60%	-3.12%	-30.34%
Net Income Q/Q Growth	-78.49%	18.79%	6.71%	0.05%	2.17%	-50.68%	47.46%	-22.55%	65.68%	10.12%	-28.68%
EPS Q/Q Growth	-78.82%	18.34%	8.04%	-1.12%	3.85%	-55.56%	50.00%	-25.97%	70.73%	9.60%	-29.21%
Operating Cash Flow Q/Q Growth	-304.00%	49.18%	309.47%	32.95%	-20.37%	43.90%	-26.31%	-58.75%	35.98%	23.36%	-3.76%
Free Cash Flow Firm Q/Q Growth	-46.52%	-8.42%	20.00%	62.08%	-3,341.67%	-65.13%	182.44%	45.17%	2.67%	9.61%	-2.77%
Invested Capital Q/Q Growth	-4.33%	0.38%	-0.77%	-2.52%	1.48%	7.16%	2.49%	-2.27%	5.10%	-1.99%	-15.93%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	77.88%	82.28%	82.87%	83.88%	84.59%	82.83%	83.19%	80.39%	84.79%	84.25%	86.69%
EBITDA Margin	-20.45%	-14.62%	-4.14%	-1.56%	-9.99%	-1.25%	14.93%	4.69%	29.37%	29.04%	19.35%
Operating Margin	-35.70%	-27.98%	-16.37%	-9.06%	-14.99%	-10.82%	8.33%	-0.55%	24.90%	27.00%	17.21%
EBIT Margin	-34.07%	-27.26%	-15.05%	-11.04%	-16.86%	-9.13%	8.22%	-2.31%	24.87%	27.21%	17.51%
Profit (Net Income) Margin	-36.15%	-27.95%	-17.48%	-12.73%	-16.79%	-10.67%	-4.10%	-14.24%	21.39%	23.57%	16.37%
Tax Burden Percent	101.41%	97.23%	110.24%	109.72%	99.78%	114.84%	-54.91%	508.44%	84.40%	82.72%	82.92%
Interest Burden Percent	104.63%	105.48%	105.41%	105.13%	99.81%	101.79%	90.87%	121.04%	101.89%	104.69%	112.78%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	12.91%	0.00%	-23.16%	16.14%	17.08%
Return on Invested Capital (ROIC)	-17.29%	-16.80%	-11.71%	-8.05%	-15.56%	-10.05%	11.66%	-0.70%	80.91%	53.26%	36.95%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.61%	-0.89%	5.16%	13.46%	6.21%	0.91%	48.71%	32.16%	112.22%	51.12%	34.05%
Return on Net Nonoperating Assets (RNNOA)	0.53%	0.28%	-1.38%	-3.69%	-1.86%	-0.25%	-16.08%	-13.98%	-49.23%	-25.74%	-22.23%
Return on Equity (ROE)	-16.76%	-16.52%	-13.10%	-11.74%	-17.43%	-10.30%	-4.42%	-14.68%	31.67%	27.52%	14.72%
Cash Return on Invested Capital (CROIC)	-7.87%	-17.79%	-13.93%	-0.74%	-5.13%	-18.88%	35.59%	10.20%	63.72%	59.96%	61.59%
Operating Return on Assets (OROA)	-11.34%	-11.35%	-7.71%	-6.67%	-10.88%	-5.05%	4.86%	-1.29%	20.18%	20.22%	11.38%
Return on Assets (ROA)	-12.04%	-11.64%	-8.96%	-7.69%	-10.83%	-5.90%	-2.42%	-7.94%	17.35%	17.51%	10.64%
Return on Common Equity (ROCE)	-16.76%	-16.52%	-13.10%	-11.74%	-17.43%	-10.30%	-4.42%	-14.68%	31.67%	27.52%	14.72%
Return on Equity Simple (ROE_SIMPLE)	-17.28%	-17.23%	-13.13%	-11.89%	-18.11%	-10.39%	-4.33%	-15.16%	29.58%	25.06%	0.00%
Net Operating Profit after Tax (NOPAT)	-157	-146	-104	-69	-123	-79	85	-4.26	510	353	211
NOPAT Margin	-24.99%	-19.59%	-11.46%	-6.34%	-10.49%	-7.58%	7.25%	-0.38%	30.66%	22.65%	14.27%
Net Nonoperating Expense Percent (NNEP)	-15.68%	-15.90%	-16.88%	-21.51%	-21.77%	-10.96%	-37.05%	-32.86%	-31.31%	2.13%	2.90%
Return On Investment Capital (ROIC_SIMPLE)	-9.43%	-9.78%	-6.98%	-4.78%	-9.01%	-5.33%	6.04%	-0.32%	34.15%	24.08%	11.57%
Cost of Revenue to Revenue	22.12%	17.72%	17.13%	16.12%	15.41%	17.17%	16.81%	19.61%	15.21%	15.75%	13.31%
SG&A Expenses to Revenue	49.58%	50.17%	46.67%	48.11%	51.19%	51.87%	46.83%	53.13%	41.47%	41.42%	47.53%
R&D to Revenue	54.81%	51.92%	45.71%	38.88%	43.80%	37.99%	24.79%	24.53%	16.28%	15.75%	21.95%
Operating Expenses to Revenue	113.58%	110.26%	99.24%	92.94%	99.58%	93.66%	74.86%	80.93%	59.89%	57.24%	69.48%
Earnings before Interest and Taxes (EBIT)	-214	-203	-136	-121	-197	-95	97	-26	414	424	258
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-128	-109	-37	-17	-117	-13	175	52	489	452	286
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.43	6.49	6.50	3.64	2.75	2.77	3.14	3.82	3.85	3.18	2.54
Price to Tangible Book Value (P/TBV)	13.15	9.83	9.16	4.80	3.55	3.42	3.70	4.32	4.14	3.37	2.66
Price to Revenue (P/Rev)	17.62	10.53	8.66	3.90	2.55	2.84	2.98	3.59	2.78	2.99	3.13
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	12.73	12.64	19.13
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	7.85%	7.91%	5.23%
Enterprise Value to Invested Capital (EV/IC)	12.28	8.60	8.41	4.72	3.54	3.31	4.71	6.15	6.00	5.98	6.60
Enterprise Value to Revenue (EV/Rev)	16.91	10.08	8.32	3.58	2.26	2.60	2.58	3.19	2.47	2.46	2.24
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	17.28	67.97	8.40	8.46	11.56
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	31.35	0.00	9.93	9.03	12.77
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	35.55	0.00	8.05	10.85	15.67
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	391.58	39.50	36.77	32.62	29.76	168.43	10.23	8.72	6.34
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	11.65	57.04	10.22	9.64	9.40
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.27	0.23	0.23	0.24	0.26	0.38	0.27	0.28	0.24	0.00	0.00
Long-Term Debt to Equity	0.22	0.23	0.23	0.24	0.25	0.37	0.26	0.28	0.24	0.00	0.00
Financial Leverage	-0.33	-0.31	-0.27	-0.27	-0.30	-0.27	-0.33	-0.43	-0.44	-0.50	-0.65
Leverage Ratio	1.39	1.42	1.46	1.53	1.61	1.74	1.82	1.85	1.83	1.57	1.38
Compound Leverage Factor	1.46	1.50	1.54	1.60	1.61	1.78	1.66	2.24	1.86	1.65	1.56
Debt to Total Capital	21.03%	19.00%	18.96%	19.25%	20.34%	27.77%	21.00%	21.93%	19.47%	0.00%	0.00%
Short-Term Debt to Total Capital	3.95%	0.20%	0.20%	0.20%	0.21%	1.26%	0.21%	0.22%	0.20%	0.00%	0.00%
Long-Term Debt to Total Capital	17.08%	18.80%	18.76%	19.06%	20.13%	26.51%	20.79%	21.71%	19.27%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	78.97%	81.00%	81.04%	80.75%	79.66%	72.23%	79.00%	78.07%	80.53%	100.00%	100.00%
Debt to EBITDA	-2.72	-2.60	-7.53	-16.33	-2.37	-31.59	1.69	5.62	0.60	0.00	0.00
Net Debt to EBITDA	3.49	3.08	8.27	19.92	2.88	19.23	-2.68	-8.57	-1.07	0.00	0.00
Long-Term Debt to EBITDA	-2.21	-2.58	-7.45	-16.16	-2.34	-30.16	1.67	5.57	0.59	0.00	0.00
Debt to NOPAT	-2.23	-1.94	-2.72	-4.03	-2.26	-5.21	3.47	-68.81	0.57	0.00	0.00
Net Debt to NOPAT	2.86	2.30	2.99	4.91	2.75	3.17	-5.52	104.83	-1.02	0.00	0.00
Long-Term Debt to NOPAT	-1.81	-1.92	-2.69	-3.98	-2.23	-4.98	3.44	-68.10	0.56	0.00	0.00
Altman Z-Score	12.01	8.79	7.68	3.81	2.09	1.72	2.32	2.30	4.05	6.06	5.34
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.20	3.73	2.78	2.89	2.46	2.54	2.25	2.27	2.86	3.04	3.55
Quick Ratio	2.92	3.25	2.29	2.45	2.03	2.08	1.80	1.80	2.13	2.44	1.70
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-71	-155	-123	-6.42	-40	-148	260	62	402	397	351
Operating Cash Flow to CapEx	-77.11%	-146.80%	37.53%	144.04%	80.05%	199.25%	366.77%	55.01%	841.52%	1,329.75%	1,323.93%
Free Cash Flow to Firm to Interest Expense	-5.39	-10.39	-10.25	-0.42	-2.98	-17.07	23.16	4.77	17.44	17.59	28.59
Operating Cash Flow to Interest Expense	-3.05	-4.29	1.60	6.43	5.30	9.57	9.07	1.61	17.43	19.45	42.42
Operating Cash Flow Less CapEx to Interest Expense	-7.00	-7.20	-2.66	1.97	-1.32	4.77	6.59	-1.32	15.36	17.99	39.21
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.33	0.42	0.51	0.60	0.65	0.55	0.59	0.56	0.81	0.74	0.65
Accounts Receivable Turnover	4.09	4.30	4.25	4.16	4.26	3.90	3.99	3.70	5.36	4.34	4.11
Inventory Turnover	3.10	2.61	1.98	1.92	1.88	1.57	1.43	1.31	1.38	1.33	1.04
Fixed Asset Turnover	2.41	2.87	3.29	3.68	3.48	2.92	3.40	3.94	7.40	6.85	6.57
Accounts Payable Turnover	0.96	0.70	0.63	0.57	0.51	0.45	0.64	1.02	1.10	1.15	0.83
Days Sales Outstanding (DSO)	89.18	84.82	85.80	87.69	85.61	93.51	91.48	98.68	68.07	84.01	88.85
Days Inventory Outstanding (DIO)	117.87	140.08	184.30	189.79	194.25	232.88	255.33	277.64	265.29	274.71	352.55
Days Payable Outstanding (DPO)	380.78	519.08	581.67	641.29	715.09	803.63	574.04	358.68	332.24	316.82	441.16
Cash Conversion Cycle (CCC)	-173.73	-294.18	-311.58	-363.81	-435.22	-477.24	-227.23	17.65	1.12	41.90	0.24
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	865	874	894	831	748	817	643	576	685	640	500
Invested Capital Turnover	0.69	0.86	1.02	1.27	1.48	1.33	1.61	1.82	2.64	2.35	2.59
Increase / (Decrease) in Invested Capital	-86	8.61	20	-63	-82	69	-175	-66	108	-44	-140
Enterprise Value (EV)	10,624	7,516	7,514	3,922	2,650	2,702	3,027	3,544	4,107	3,829	3,300
Market Capitalization	11,073	7,852	7,824	4,263	2,987	2,952	3,497	3,991	4,629	4,653	4,620
Book Value per Share	$8.76	$7.96	$7.82	$7.54	$6.89	$6.70	$6.88	$6.35	$7.21	$9.05	$11.02
Tangible Book Value per Share	$5.61	$5.25	$5.55	$5.71	$5.34	$5.42	$5.85	$5.62	$6.70	$8.54	$10.51
Total Capital	1,664	1,493	1,484	1,451	1,363	1,477	1,408	1,337	1,493	1,465	1,819
Total Debt	350	284	281	279	277	410	296	293	291	0.00	0.00
Total Long-Term Debt	284	281	278	276	274	392	293	290	288	0.00	0.00
Net Debt	-449	-335	-309	-341	-337	-250	-470	-447	-523	-825	-1,320
Capital Expenditures (CapEx)	52	43	51	69	90	42	28	38	48	33	39
Debt-free, Cash-free Net Working Capital (DFCFNWC)	50	84	87	107	39	56	58	27	195	198	66
Debt-free Net Working Capital (DFNWC)	584	582	521	646	574	691	594	636	968	950	1,386
Net Working Capital (NWC)	519	579	518	643	571	673	591	633	965	950	1,386
Net Nonoperating Expense (NNE)	70	62	54	70	74	32	133	154	154	-14	-31
Net Nonoperating Obligations (NNO)	-449	-335	-309	-341	-337	-250	-470	-468	-518	-825	-1,320
Total Depreciation and Amortization (D&A)	86	94	99	104	80	82	79	78	75	29	27
Debt-free, Cash-free Net Working Capital to Revenue	7.91%	11.33%	9.65%	9.78%	3.31%	5.42%	4.91%	2.44%	11.71%	12.74%	4.49%
Debt-free Net Working Capital to Revenue	93.02%	78.01%	57.64%	59.06%	48.99%	66.55%	50.60%	57.17%	58.21%	61.00%	93.89%
Net Working Capital to Revenue	82.56%	77.60%	57.31%	58.80%	48.75%	64.76%	50.34%	56.90%	58.03%	61.00%	93.89%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.52)	($1.38)	($1.03)	($0.90)	($1.25)	($0.70)	($0.30)	($0.97)	$2.14	$2.22	$1.47
Adjusted Weighted Average Basic Shares Outstanding	149.21M	152.55M	156.14M	156.04M	157.79M	159.24M	161.97M	163.54M	166.22M	165.39M	164.70M
Adjusted Diluted Earnings per Share	($1.52)	($1.38)	($1.03)	($0.90)	($1.25)	($0.70)	($0.30)	($0.97)	$2.10	$2.17	$1.43
Adjusted Weighted Average Diluted Shares Outstanding	149.21M	152.55M	156.14M	156.04M	157.79M	159.24M	161.97M	163.54M	169.73M	169.20M	168.74M
Adjusted Basic & Diluted Earnings per Share	$0.00	($1.38)	($1.03)	($0.90)	($1.25)	($0.70)	($0.30)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	150.74M	151.48M	153.42M	155.11M	157.05M	158.80M	160.94M	164.39M	167.08M	162.61M	166.65M
Normalized Net Operating Profit after Tax (NOPAT)	-157	-146	-104	-69	-113	-79	85	-4.26	290	353	211
Normalized NOPAT Margin	-24.99%	-19.59%	-11.46%	-6.34%	-9.69%	-7.58%	7.25%	-0.38%	17.43%	22.65%	14.27%
Pre Tax Income Margin	-35.65%	-28.75%	-15.86%	-11.60%	-16.83%	-9.29%	7.47%	-2.80%	25.34%	28.49%	19.75%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-16.16	-13.65	-11.32	-7.82	-14.52	-10.95	8.60	-1.97	17.96	18.77	21.05
NOPAT to Interest Expense	-11.85	-9.81	-8.62	-4.50	-9.03	-9.09	7.59	-0.33	22.15	15.62	17.15
EBIT Less CapEx to Interest Expense	-20.11	-16.57	-15.58	-12.29	-21.14	-15.75	6.13	-4.91	15.89	17.31	17.85
NOPAT Less CapEx to Interest Expense	-15.80	-12.73	-12.88	-8.96	-15.65	-13.89	5.12	-3.26	20.07	14.16	13.95
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	54.56%	0.00%

This table displays calculated financial ratios and metrics derived from Alkermes' official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	166,649,934.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	166,649,934.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-0.40
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	50.95%	23.89%	21.83%	-35.35%	-0.73%	13.91%	-12.52%	-2.12%	4.24%	-10.57%	28.19%
EBITDA Growth	332.48%	-45.81%	569.18%	-60.44%	3.96%	132.34%	-55.83%	-14.36%	-13.72%	-62.13%	-176.50%
EBIT Growth	235.26%	-52.64%	494.98%	-60.13%	17.88%	198.67%	-64.71%	-16.25%	-15.68%	-62.90%	-422.99%
NOPAT Growth	307.51%	53.80%	568.16%	-68.01%	0.12%	-7.21%	-66.19%	-13.32%	-17.02%	-65.98%	-378.04%
Net Income Growth	174.65%	499.16%	188.01%	-61.46%	93.44%	29.90%	-39.00%	-4.66%	-10.41%	-66.32%	-395.94%
EPS Growth	171.79%	483.33%	184.00%	-61.59%	96.43%	27.54%	-38.10%	-1.89%	-10.91%	-67.05%	-407.69%
Operating Cash Flow Growth	15,853.28%	10,142.31%	199.09%	-32.30%	-18.17%	77.55%	368.12%	2.86%	24.61%	-10.68%	-267.74%
Free Cash Flow Firm Growth	621.28%	-74.38%	-6,322.67%	-37.68%	227.75%	337.28%	261.22%	-18.00%	52.62%	2.14%	-1,505.71%
Invested Capital Growth	10.47%	18.80%	21.69%	-8.16%	0.27%	-6.49%	-19.22%	-6.61%	-8.99%	-21.94%	357.47%
Revenue Q/Q Growth	-38.30%	-0.91%	-7.18%	13.92%	-5.26%	13.71%	-28.72%	27.45%	0.90%	-2.45%	2.18%
EBITDA Q/Q Growth	-63.97%	-32.26%	-29.54%	130.07%	-5.32%	51.38%	-86.61%	346.08%	-4.61%	-33.56%	-127.06%
EBIT Q/Q Growth	-68.18%	-38.86%	-20.38%	157.38%	-5.92%	54.91%	-90.59%	510.82%	-5.28%	-31.84%	-181.91%
NOPAT Q/Q Growth	-68.38%	70.75%	-76.09%	147.84%	-1.04%	58.25%	-91.29%	535.48%	-5.26%	-35.11%	-171.17%
Net Income Q/Q Growth	-79.85%	136.15%	-67.35%	148.07%	1.12%	58.59%	-84.67%	287.72%	-4.98%	-40.38%	-234.74%
EPS Q/Q Growth	-79.71%	146.43%	-69.57%	152.38%	3.77%	60.00%	-85.23%	300.00%	-5.77%	-40.82%	-237.93%
Operating Cash Flow Q/Q Growth	-53.78%	7.55%	-80.32%	591.82%	-44.13%	133.36%	-48.10%	52.01%	-32.31%	67.27%	-197.46%
Free Cash Flow Firm Q/Q Growth	-88.55%	59.58%	-326.75%	250.34%	-39.76%	112.91%	-16.40%	-23.53%	12.13%	42.49%	-1,250.55%
Invested Capital Q/Q Growth	-2.09%	5.10%	7.66%	-17.11%	6.91%	-1.99%	-7.00%	-4.17%	4.18%	-15.93%	445.02%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	83.86%	81.42%	83.26%	84.60%	83.31%	85.55%	83.95%	87.34%	86.91%	87.98%	84.33%
EBITDA Margin	28.35%	19.38%	14.71%	29.71%	29.69%	39.53%	7.43%	26.00%	24.58%	16.74%	-4.43%
Operating Margin	23.41%	14.47%	12.36%	27.53%	27.70%	37.84%	4.50%	23.80%	22.60%	15.11%	-12.29%
EBIT Margin	23.45%	14.47%	12.41%	28.04%	27.85%	37.94%	5.01%	24.00%	22.53%	15.74%	-12.62%
Profit (Net Income) Margin	12.54%	29.88%	10.51%	22.89%	24.43%	34.07%	7.33%	22.30%	21.00%	12.83%	-16.92%
Tax Burden Percent	51.52%	193.39%	78.50%	78.27%	83.81%	86.23%	88.13%	83.08%	82.15%	81.72%	107.35%
Interest Burden Percent	103.77%	106.76%	107.87%	104.27%	104.67%	104.14%	166.07%	111.83%	113.45%	99.76%	124.92%
Effective Tax Rate	1.24%	-175.31%	16.98%	18.90%	15.82%	14.22%	11.87%	16.92%	17.85%	18.28%	0.00%
Return on Invested Capital (ROIC)	59.27%	105.14%	26.39%	52.76%	53.81%	76.33%	9.01%	50.38%	45.28%	31.98%	-8.10%
ROIC Less NNEP Spread (ROIC-NNEP)	66.24%	112.77%	26.20%	52.41%	53.19%	75.29%	7.57%	49.24%	44.20%	31.80%	-125.02%
Return on Net Nonoperating Assets (RNNOA)	-31.97%	-49.48%	-10.64%	-26.33%	-26.98%	-37.90%	-3.93%	-29.24%	-25.97%	-20.76%	-2.14%
Return on Equity (ROE)	27.31%	55.66%	15.75%	26.43%	26.83%	38.42%	5.09%	21.14%	19.30%	11.21%	-10.24%
Cash Return on Invested Capital (CROIC)	63.06%	63.72%	63.35%	65.57%	55.55%	59.96%	70.70%	60.55%	57.87%	61.59%	-119.59%
Operating Return on Assets (OROA)	17.68%	11.74%	10.59%	19.25%	18.91%	28.20%	3.60%	16.20%	15.28%	10.23%	-6.22%
Return on Assets (ROA)	9.45%	24.24%	8.97%	15.71%	16.58%	25.32%	5.28%	15.05%	14.24%	8.34%	-8.34%
Return on Common Equity (ROCE)	27.31%	55.66%	15.75%	26.43%	26.83%	38.42%	5.09%	21.14%	19.30%	11.21%	-10.24%
Return on Equity Simple (ROE_SIMPLE)	15.84%	0.00%	34.62%	22.49%	25.80%	0.00%	23.33%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	88	150	36	89	88	140	12	77	73	47	-34
NOPAT Margin	23.12%	39.85%	10.26%	22.33%	23.32%	32.46%	3.97%	19.77%	18.56%	12.35%	-8.60%
Net Nonoperating Expense Percent (NNEP)	-6.97%	-7.64%	0.19%	0.35%	0.62%	1.03%	1.44%	1.14%	1.08%	0.17%	116.92%
Return On Investment Capital (ROIC_SIMPLE)	5.35%	10.07%	2.33%	5.66%	5.58%	9.53%	0.80%	4.75%	4.22%	2.61%	-1.04%
Cost of Revenue to Revenue	16.14%	18.58%	16.74%	15.40%	16.69%	14.45%	16.05%	12.66%	13.09%	12.02%	15.67%
SG&A Expenses to Revenue	41.05%	44.98%	51.30%	42.12%	39.77%	34.19%	56.02%	43.73%	43.58%	48.68%	67.34%
R&D to Revenue	17.03%	19.59%	19.30%	14.94%	15.84%	13.53%	23.43%	19.81%	20.74%	24.19%	26.30%
Operating Expenses to Revenue	60.44%	66.95%	70.90%	57.07%	55.61%	47.72%	79.45%	63.54%	64.31%	72.87%	96.62%
Earnings before Interest and Taxes (EBIT)	89	55	43	112	105	163	15	94	89	61	-50
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	108	73	52	119	112	170	23	102	97	64	-17
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.20	3.85	3.60	3.18	3.57	3.18	3.55	2.90	2.86	2.54	3.36
Price to Tangible Book Value (P/TBV)	3.46	4.14	3.86	3.40	3.81	3.37	3.76	3.06	3.00	2.66	0.00
Price to Revenue (P/Rev)	2.73	2.78	2.62	2.70	3.06	2.99	3.55	3.13	3.26	3.13	3.77
Price to Earnings (P/E)	19.58	12.73	10.29	13.94	13.56	12.64	15.13	13.46	14.68	19.13	38.96
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	5.11%	7.85%	9.72%	7.17%	7.37%	7.91%	6.61%	7.43%	6.81%	5.23%	2.57%
Enterprise Value to Invested Capital (EV/IC)	5.58	6.00	5.43	5.57	6.08	5.98	7.48	6.42	6.41	6.60	2.52
Enterprise Value to Revenue (EV/Rev)	2.28	2.47	2.32	2.26	2.64	2.46	2.94	2.43	2.51	2.24	4.39
Enterprise Value to EBITDA (EV/EBITDA)	6.60	8.40	7.51	9.69	11.16	8.46	10.51	9.01	9.75	11.56	29.50
Enterprise Value to EBIT (EV/EBIT)	7.66	9.93	8.54	11.37	12.59	9.03	11.25	9.70	10.56	12.77	35.48
Enterprise Value to NOPAT (EV/NOPAT)	8.02	8.05	7.19	9.35	10.90	10.85	13.52	11.54	12.61	15.67	47.80
Enterprise Value to Operating Cash Flow (EV/OCF)	12.31	10.23	9.01	9.10	11.15	8.72	8.62	7.03	7.05	6.34	26.79
Enterprise Value to Free Cash Flow (EV/FCFF)	9.28	10.22	9.40	8.14	10.96	9.64	9.45	10.24	10.56	9.40	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.21	0.24	0.23	0.23	0.22	0.00	0.00	0.00	0.00	0.00	0.86
Long-Term Debt to Equity	0.21	0.24	0.23	0.22	0.22	0.00	0.00	0.00	0.00	0.00	0.85
Financial Leverage	-0.48	-0.44	-0.41	-0.50	-0.51	-0.50	-0.52	-0.59	-0.59	-0.65	0.02
Leverage Ratio	1.76	1.83	1.79	1.71	1.67	1.57	1.52	1.53	1.48	1.38	1.94
Compound Leverage Factor	1.83	1.95	1.93	1.79	1.75	1.64	2.52	1.71	1.68	1.38	2.43
Debt to Total Capital	17.69%	19.47%	18.78%	18.40%	18.27%	0.00%	0.00%	0.00%	0.00%	0.00%	46.30%
Short-Term Debt to Total Capital	0.18%	0.20%	0.19%	0.19%	0.19%	0.00%	0.00%	0.00%	0.00%	0.00%	0.81%
Long-Term Debt to Total Capital	17.51%	19.27%	18.58%	18.21%	18.08%	0.00%	0.00%	0.00%	0.00%	0.00%	45.49%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	82.31%	80.53%	81.22%	81.60%	81.73%	100.00%	100.00%	100.00%	100.00%	100.00%	53.70%
Debt to EBITDA	0.53	0.60	0.54	0.82	0.81	0.00	0.00	0.00	0.00	0.00	6.49
Net Debt to EBITDA	-1.28	-1.07	-0.97	-1.92	-1.80	0.00	0.00	0.00	0.00	0.00	4.18
Long-Term Debt to EBITDA	0.52	0.59	0.54	0.82	0.80	0.00	0.00	0.00	0.00	0.00	6.38
Debt to NOPAT	0.64	0.57	0.52	0.80	0.79	0.00	0.00	0.00	0.00	0.00	10.52
Net Debt to NOPAT	-1.55	-1.02	-0.93	-1.85	-1.75	0.00	0.00	0.00	0.00	0.00	6.77
Long-Term Debt to NOPAT	0.64	0.56	0.52	0.79	0.79	0.00	0.00	0.00	0.00	0.00	10.33
Altman Z-Score	3.26	3.50	3.71	3.29	3.95	5.64	6.35	5.37	5.95	5.08	1.69
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.91	2.86	3.20	2.99	3.45	3.04	3.33	3.23	3.67	3.55	2.27
Quick Ratio	2.44	2.13	2.31	2.41	2.81	2.44	2.71	2.71	3.09	1.70	1.53
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	26	42	-95	143	86	184	154	118	132	188	-2,162
Operating Cash Flow to CapEx	690.02%	642.83%	266.15%	2,060.24%	990.40%	1,949.59%	1,176.74%	1,022.13%	587.22%	0.00%	-4,061.33%
Free Cash Flow to Firm to Interest Expense	4.39	6.95	-15.96	24.10	14.40	39.58	0.00	0.00	0.00	15.31	-103.49
Operating Cash Flow to Interest Expense	16.60	17.71	3.53	24.53	13.60	40.96	0.00	0.00	0.00	13.85	-7.93
Operating Cash Flow Less CapEx to Interest Expense	14.20	14.96	2.20	23.34	12.23	38.86	0.00	0.00	0.00	13.94	-8.13
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.75	0.81	0.85	0.69	0.68	0.74	0.72	0.68	0.68	0.65	0.49
Accounts Receivable Turnover	5.35	5.36	5.90	4.30	4.27	4.34	4.77	4.17	4.22	4.11	4.30
Inventory Turnover	1.32	1.38	1.32	1.31	1.32	1.33	1.24	1.16	1.11	1.04	0.80
Fixed Asset Turnover	4.87	7.40	6.33	5.52	5.44	6.85	6.60	6.51	6.44	6.57	6.87
Accounts Payable Turnover	1.04	1.10	1.28	1.04	1.26	1.15	1.20	0.92	1.13	0.83	0.87
Days Sales Outstanding (DSO)	68.25	68.07	61.85	84.83	85.47	84.01	76.50	87.45	86.56	88.85	84.85
Days Inventory Outstanding (DIO)	276.24	265.29	275.97	278.46	276.10	274.71	295.40	315.20	328.35	352.55	454.54
Days Payable Outstanding (DPO)	350.18	332.24	285.07	349.93	290.64	316.82	303.20	395.80	322.42	441.16	418.25
Cash Conversion Cycle (CCC)	-5.69	1.12	52.75	13.35	70.93	41.90	68.70	6.86	92.49	0.24	121.14
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	651	685	737	611	653	640	595	571	594	500	2,724
Invested Capital Turnover	2.56	2.64	2.57	2.36	2.31	2.35	2.27	2.55	2.44	2.59	0.94
Increase / (Decrease) in Invested Capital	62	108	131	-54	1.78	-44	-142	-40	-59	-140	2,128
Enterprise Value (EV)	3,633	4,107	4,000	3,405	3,970	3,829	4,453	3,664	3,813	3,300	6,865
Market Capitalization	4,337	4,629	4,517	4,078	4,609	4,653	5,370	4,718	4,952	4,620	5,893
Book Value per Share	$8.14	$7.21	$7.47	$7.59	$7.85	$9.05	$9.30	$9.85	$10.50	$11.02	$10.51
Tangible Book Value per Share	$7.52	$6.70	$6.97	$7.09	$7.34	$8.54	$8.78	$9.34	$9.99	$10.51	($3.77)
Total Capital	1,647	1,493	1,545	1,573	1,581	1,465	1,512	1,625	1,733	1,819	3,262
Total Debt	291	291	290	289	289	0.00	0.00	0.00	0.00	0.00	1,510
Total Long-Term Debt	288	288	287	286	286	0.00	0.00	0.00	0.00	0.00	1,484
Net Debt	-704	-523	-518	-673	-639	-825	-916	-1,054	-1,139	-1,320	972
Capital Expenditures (CapEx)	14	17	7.93	7.09	8.24	9.77	8.40	15	17	-1.07	4.08
Debt-free, Cash-free Net Working Capital (DFCFNWC)	76	195	268	154	205	198	151	114	156	66	274
Debt-free Net Working Capital (DFNWC)	965	968	1,013	1,030	1,113	950	1,035	1,129	1,267	1,386	786
Net Working Capital (NWC)	962	965	1,010	1,027	1,110	950	1,035	1,129	1,267	1,386	759
Net Nonoperating Expense (NNE)	40	38	-0.87	-2.24	-4.19	-6.94	-10	-9.85	-9.58	-1.86	33
Net Nonoperating Obligations (NNO)	-704	-518	-518	-673	-639	-825	-916	-1,054	-1,139	-1,320	972
Total Depreciation and Amortization (D&A)	19	19	8.06	6.66	6.97	6.85	7.42	7.82	8.08	3.85	32
Debt-free, Cash-free Net Working Capital to Revenue	4.75%	11.71%	15.51%	10.18%	13.59%	12.74%	10.00%	7.55%	10.27%	4.49%	17.52%
Debt-free Net Working Capital to Revenue	60.65%	58.21%	58.68%	68.28%	73.98%	61.00%	68.39%	75.02%	83.30%	93.89%	50.29%
Net Working Capital to Revenue	60.46%	58.03%	58.50%	68.08%	73.78%	61.00%	68.39%	75.02%	83.30%	93.89%	48.59%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.29	$0.67	$0.22	$0.54	$0.57	$0.89	$0.14	$0.53	$0.50	$0.30	($0.40)
Adjusted Weighted Average Basic Shares Outstanding	166.61M	166.22M	167.98M	168.32M	163.37M	165.39M	163.41M	164.96M	165.09M	164.70M	166.20M
Adjusted Diluted Earnings per Share	$0.28	$0.69	$0.21	$0.53	$0.55	$0.88	$0.13	$0.52	$0.49	$0.29	($0.40)
Adjusted Weighted Average Diluted Shares Outstanding	171.90M	169.73M	172.98M	170.98M	167.03M	169.20M	168.74M	168.36M	168.51M	168.74M	166.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	166.88M	167.08M	169.22M	164.67M	161.80M	162.61M	164.90M	165.08M	165.12M	166.65M	166.68M
Normalized Net Operating Profit after Tax (NOPAT)	88	38	36	89	88	140	12	77	73	47	-34
Normalized NOPAT Margin	23.12%	10.13%	10.26%	22.33%	23.32%	32.46%	3.97%	19.77%	18.56%	12.35%	-8.60%
Pre Tax Income Margin	24.34%	15.45%	13.39%	29.24%	29.15%	39.51%	8.32%	26.84%	25.56%	15.70%	-15.76%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	14.88	9.02	7.28	18.81	17.55	35.10	0.00	0.00	0.00	4.93	-2.37
NOPAT to Interest Expense	14.67	24.84	6.01	14.97	14.70	30.03	0.00	0.00	0.00	3.87	-1.62
EBIT Less CapEx to Interest Expense	12.47	6.27	5.95	17.62	16.18	33.00	0.00	0.00	0.00	5.02	-2.57
NOPAT Less CapEx to Interest Expense	12.26	22.09	4.69	13.78	13.32	27.92	0.00	0.00	0.00	3.96	-1.81
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	29.33%	60.08%	54.56%	0.00%	33.17%	0.00%	0.00%	18.14%

Financials Breakdown Chart

Key Financial Trends

Here are the key trends from Alkermes (ALKS) quarterly statements over the last several years, focusing on the four most recent years and highlighting notable patterns for retail investors.

Gross margin expansion in Q4 2025. Gross profit was $338.34 million on revenue of $384.55 million, a margin near 88%, up from Q4 2024 gross profit of $307.35 million on revenue $429.99 million (margin ~72%).
Consistent positive operating cash flow in 2025 quarters. Net cash from continuing operating activities was roughly $98.8M (Q1 2025), $150.2M (Q2 2025), $101.7M (Q3 2025), and $170.1M (Q4 2025), indicating ongoing cash generation.
Strong liquidity indicators as of mid-2025. Cash & equivalents around $616.4M in Q3 2025, with short-term investments about $494.7M and total current assets near $1.75B versus total current liabilities of about $474.4M (current ratio well above 3x).
Significant investing cash inflows in Q4 2025. Sale/maturity of investments totaled $377.11M, contributing to net cash from continuing investing activities of $322.35M and boosting overall liquidity for the period.
Solid equity base supporting balance sheet strength. Total Common Equity around $1.73B and Total Equity near $1.73B as of Q3 2025, underpinning a sizable equity cushion despite ongoing R&D/SG&A spend.
Revenue shows quarter-to-quarter volatility. For example, Q4 2025 revenue ($384.55M) edged down from Q3 2025 ($394.19M), and quarterly revenue has fluctuated across 2025 and prior years.
Earnings per share have fluctuated quarter-to-quarter. Diluted EPS in Q4 2025 was $0.29 vs $0.52 in Q3 2025, reflecting varying net income per share despite similar operating performance in some periods.
Financing activity was modest in the latest quarter. Net cash from financing activities in Q4 2025 was a relatively small amount, suggesting financing was not a major driver of liquidity in that period.
Q4 2025 net income declined year-over-year. Net income attributable to common shareholders dropped to $48.3M in Q4 2025 from $144.1M in Q4 2024, signaling weaker profitability on a YoY basis.
operating expenses rose in 2025 versus 2024, pressuring margins. Selling, General & Administrative (SG&A) was $187.20M and Research & Development (R&D) was $93.04M in Q4 2025, higher than many prior-year quarters, contributing to higher total operating expenses relative to some periods.

05/16/26 10:06 AM ETAI Generated. May Contain Errors.

Alkermes Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Alkermes' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Alkermes' net income appears to be on a downward trend, with a most recent value of $241.66 million in 2025, falling from -$227.16 million in 2015. The previous period was $367.07 million in 2024. See Alkermes' forecast for analyst expectations on what's next for the company.

Alkermes' total operating income in 2025 was $253.96 million, based on the following breakdown:

Total Gross Profit: $1.28 billion
Total Operating Expenses: $1.03 billion

Over the last 10 years, Alkermes' total revenue changed from $628.34 million in 2015 to $1.48 billion in 2025, a change of 134.9%.

Alkermes' total liabilities were at $667.70 million at the end of 2025, a 13.1% increase from 2024, and a 23.3% increase since 2015.

In the past 10 years, Alkermes' cash and equivalents has ranged from $181.11 million in 2015 to $457.47 million in 2023, and is currently $388.57 million as of their latest financial filing in 2025.

Over the last 10 years, Alkermes' book value per share changed from 8.76 in 2015 to 11.02 in 2025, a change of 25.8%.

Related Companies

Financial statements for NASDAQ:ALKS last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alkermes (ALKS) Financials

Financials Breakdown Chart

Key Financial Trends

Alkermes Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alkermes (ALKS) Financials

Annual Income Statements for Alkermes

Quarterly Income Statements for Alkermes

Annual Cash Flow Statements for Alkermes

Quarterly Cash Flow Statements for Alkermes

Annual Balance Sheets for Alkermes

Quarterly Balance Sheets for Alkermes

Annual Metrics And Ratios for Alkermes

Quarterly Metrics And Ratios for Alkermes

Financials Breakdown Chart

Key Financial Trends

Alkermes Financials - Frequently Asked Questions

When does Alkermes' fiscal year end?

How has Alkermes' net income changed over the last 10 years?

What is Alkermes' operating income?

How has Alkermes' revenue changed over the last 10 years?

How much debt does Alkermes have?

How much cash does Alkermes have?

How has Alkermes' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools